To BaP or not to BaP? That is the question.
Goldstein
L S
LS
D000280:Administration, Inhalation; D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D001564:Benzo(a)pyrene / Q000633:toxicity*; D015197:Carcinogenicity Tests / Q000379:methods; D002274:Carcinogens, Environmental / Q000633:toxicity*; D002985:Clinical Protocols; D003033:Coal Tar / Q000633:toxicity*; D004195:Disease Models, Animal; D004781:Environmental Exposure / Q000009:adverse effects; D006801:Humans; D008175:Lung Neoplasms / Q000139:chemically induced; D051379:Mice; D011084:Polycyclic Aromatic Hydrocarbons / Q000633:toxicity*; D012107:Research Design; D018570:Risk Assessment / Q000379:methods; D012878:Skin Neoplasms / Q000139:chemically induced; D013274:Stomach Neoplasms / Q000139:chemically induced; D014481:United States; D014484:United States Environmental Protection Agency
D002274:Carcinogens, Environmental; D011084:Polycyclic Aromatic Hydrocarbons; D001564:Benzo(a)pyrene; D003033:Coal Tar